Ontology highlight
ABSTRACT: Background
Bryophyllum pinnatum is a herbal medicine from Indonesia which has an anti-inflammatory effect. Adenosine monophosphate-activated protein kinase (AMPK) and inducible nitric oxide synthase (iNOS) play a function in thickening and inflammation in atherosclerosis disease.Objective
This research aims conducted to know the potential of Bryophyllum pinnatum as a therapy for atherosclerosis by targeting AMPK and iNOS.Methods
We employed a molecular docking technique to interact active compounds of Bryohyllum pinnatum with AMPK and iNOS, which were retrieved on the protein databank. Molecular docking analysis utilizing tools such as Pyrx 9.5, Pymol, and Discovery Studio, to support the interaction between the compound and protein. Molecular Dynamic (MD) simulation also performed using CABS-FLEX 2.0 server to know the stability interaction.Results
Bryophillin B was an active compound that possesses significant binding to AMPK and iNOS. It had same binding pocket as native ligand, and Bryophyllin B has a stronger interaction with AMPK. Based on the RMSF, the interaction biding complex Bryophyllin B with AMPK and iNOS were stable.Conclusion
Bryophillin B was predicted to have potential therapy for atherosclerosis disease.
SUBMITTER: Yuniwati Y
PROVIDER: S-EPMC9233472 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH 20220601 2
<h4>Background</h4><i>Bryophyllum pinnatum</i> is a herbal medicine from Indonesia which has an anti-inflammatory effect. Adenosine monophosphate-activated protein kinase (AMPK) and inducible nitric oxide synthase (iNOS) play a function in thickening and inflammation in atherosclerosis disease.<h4>Objective</h4>This research aims conducted to know the potential of <i>Bryophyllum pinnatum</i> as a therapy for atherosclerosis by targeting AMPK and iNOS.<h4>Methods</h4>We employed a molecular docki ...[more]